Related Experiment Videos

Proteases produced by activated neutrophils are able to release soluble CD23 fragments endowed with proinflammatory

C Brignone1, O Munoz, M Batoz

  • 1INSERM U343, Hôpital de L'Archet, F-06202 Nice cedex 3, France.

Insights

Activated neutrophils release soluble CD23 fragments, which promote inflammation. Serine proteases from neutrophils cleave CD23 on B cells, stimulating monocytes and contributing to inflammatory disorders.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Polymorphonuclear neutrophils (PMNs) are key players in tissue damage during chronic inflammation.
  • Elevated soluble CD23 levels are observed in patients with inflammatory conditions.
  • CD23 is implicated in regulating inflammatory responses.

Purpose of the Study:

  • To investigate the mechanism of soluble CD23 fragment release.
  • To determine the role of PMN-derived proteases in CD23 cleavage.
  • To assess the inflammatory potential of CD23 fragments generated by proteolysis.

Main Methods:

  • Co-culture of activated PMNs with CD23+ B cells.
  • Treatment with serine protease inhibitors and purified proteases (leukocyte elastase, cathepsin G).
  • Stimulation assays with monocytes using released CD23 fragments.

Main Results:

  • Activated PMNs induced significant release of soluble CD23 from B cells.
  • Serine proteases, notably leukocyte elastase and cathepsin G, were identified as key enzymes cleaving membrane CD23.
  • Inhibitors of serine proteases, like a1-antitrypsin, blocked CD23 cleavage.
  • Soluble CD23 fragments stimulated monocytes to produce oxidative burst and pro-inflammatory cytokines.

Conclusions:

  • PMN-derived serine proteases cleave CD23 on B cells, releasing soluble fragments.
  • These soluble CD23 fragments possess pro-inflammatory activity, stimulating monocytes.
  • This mechanism contributes to the inflammatory processes in chronic inflammatory disorders.

Related Concept Videos